BackgroundThe Coronavirus diseases (COVID-19) pandemic is not abating and there is no approved treatment yet. The development of vaccines is hoped to help in addressing this disease outbreak. However, in the face of anti-vaccines uprise, it is important to understand the factors that may influence the uptake of COVID-19 vaccines as this will influence how successful the fight against COVID-19 will be in the long term.MethodsA cross-sectional study among 776 adult Nigerians (age ≥18 years) was conducted in the 36 States of Nigeria and the Capital City with online questionnaire. The questionnaire consisted of 5 sections: socio-demographic characteristics of respondents, respondent’s knowledge of COVID-19, respondents risk perception of COVID-19, vaccination history of respondents, and willingness to receive COVID-19 vaccine. Descriptive analysis of variables was done and multivariate analysis using logistic regression was carried out to determine the predictors of uptake of a potential COVID-19 vaccine. The level of significance was predetermined at a p-value < 0.05. Data analysis was done with SPSS version 21.ResultsMost of the respondents were male (58.1%). Most participants were willing to take a potential COVID-19 vaccine (58.2%), while 19.2% would not take it with 22.6% indecisive. 53.5% would prefer a single dose COVID-19 vaccine. For vaccine uptake, being male (p= 0.002) and the perception that “vaccines are good” (p< 0.001) were the positive predictor of uptake of a potential COVID-19 vaccine.ConclusionMost Nigerians were willing to take a potential COVID-19 vaccine with the male gender and perception that “vaccines are good” being positive predictors. There is a need for public enlightenment aim at encouraging those that are indecisive or averse to receiving COVID-19 vaccines.
Background: The Coronavirus Disease 2019(COVID-19) is far from over, although appreciable progress have been made to limit the devastating effects of the pandemic across the globe. Adequate knowledge and risk perception is a critical assessment that is required to ensure proper preventive measures. This study assessed these among Nigerians. Methods: The study was a cross-sectional assessment of 776 consenting Nigerian adults that were distributed across the 6 geo-political zones and the Federal Capital Territory. Online pre-tested, semi-structured questionnaire were used to obtain the socio-demographic data and assessed the knowledge and risk perception of the participants to COVID-19. The knowledge of COVID-19 was assessed based on the number of accurate responses given in comparison to average scores. Chi-square analysis was computed to analysis the association between socio-demographic characteristics and knowledge of COVID-19 and risk perception. Data analysis was done using SPSS version 21, the level of significance was set at value p<0.05 at 95% confidence interval. Results: Majority of the participants were male 451 (58.1%), there was a good knowledge of COVID-19 among 90.3% of respondents with 57% having positive risk perception. There was a statistically significant relationship between good knowledge and positive risk perception of COVID-19 (p < 0.001). Annual income (p =0.012) and the perception that vaccines are good significantly predict positive risk perception of COVID-19 among the respondents. Conclusion: A good knowledge of COVID-19 and vaccination against the virus were the two most important factors that determined risk perception among the population. This may be because of the widespread advocacy, and it portends a good omen at combating COVID-19 menace. Key words: COVID-19, Risk perception, Nigerians
Background: COVID-19 Vaccine hesitancy is increasing globally, and this threatens the world ability to bring the pandemic under control. The way the media reports on the vaccine may influence or affect how the population perceive the safety and efficacy of the vaccine. Methods: The aim of this study was to determine how newspapers in Nigeria report stories about the vaccine and the side effects of the vaccine amidst the growing fear on the safety of the vaccine. A total of 4 national daily newspapers were randomly selected for the study. These are Leadership, Guardian, Nation and Punch newspapers. The study was anchored on agenda setting theory. Quantitative content analysis research was used for the study. The duration of the study was the day the vaccine was introduced in Nigeria: March 1st,2021 to July 31st, 2021. An Excel sheet served as the instrument for data collection and analysis done using SPSS version 25 with the level of significance predetermined at a p-value less than 0.05. Results: Key findings from this research were: Government officials and technical experts were predominantly used by the newspapers as the source of their information. There was a mixed reporting of vaccine side effects with a significant difference between those newspaper publications that reported vaccine side effects and those that did not. Amongst those that reported side effects, there was also a significant difference between those that communicated how and where to report the side effects as against those that did not. Conclusion: As part of the effort to curtail vaccine hesitancy, a continuous improvement in communicating the vaccine efficacy and safety is needed. Keywords: coverage; side-effects; newspaper, COVID-19; vaccine Nigeria;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.